Debut Plus

₹20.91

▼ -0.09 -0.43%

As of 23 Oct 2026 · delayed

NSE Listed

Balaxi Pharmaceuticals Ltd. (BALAXI)

Volume: 40,139Avg Vol 1W: 31,704.2Avg Vol 1M: 23,637.7552W Range:₹15.2₹43.85
NSE BSE www.balaxipharma.in AI Report
Key Ratios
Checked 13h ago
Market Cap₹115 Cr
Current Price₹20.91
Previous Close₹21
High / Low (52w)₹43.85 / ₹15.2
Volume40,139
Avg Vol (1W)31,704.2
Avg Vol (1M)23,637.75
Stock P/E47.52
Book Value₹45.12
Dividend Yield0%
ROE56.9%
ROA72.1%
Revenue (TTM)₹273 Cr
Revenue Growth21.3%
Profit Margin86.8%
Total Debt₹21 Cr
Shares Outstanding6 Cr
Face Value₹2
EPS (TTM)₹0.44
P/B0.46
Debt / Equity0.23
50 DMA₹22.94
200 DMA₹23.3
Day change-0.43%
Price Chart
₹20.91▼ 50.31% · 1Y
₹44₹1615.0L
2025-10-27
2026-10-23

20-day avg volume: 24K shares

Pros
  • Healthy return on equity of 56.9%.
  • Company is almost debt-free.
  • Stock trades below its book value.
Cons
  • Revenue fell 69% YoY.
Quarterly Results
MetricSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Revenue₹77 Cr₹73 Cr₹76 Cr₹71 Cr₹56 Cr₹73 Cr₹71 Cr₹81 Cr
EBITDA₹6 Cr₹7 Cr₹10 Cr₹2 Cr₹2 Cr₹3 Cr₹2 Cr₹3 Cr
Net Profit₹5 Cr₹5 Cr₹9 Cr₹0 Cr₹0 Cr₹0 Cr₹1 Cr₹1 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Mar 2026Jun 2026
Revenue₹289 Cr₹10 Cr₹17 Cr₹19 Cr₹25 Cr₹273 Cr₹20 Cr₹16 Cr
EBITDA₹32 Cr₹0 Cr₹1 Cr₹5 Cr₹3 Cr₹9 Cr₹1 Cr₹-1 Cr
Net Profit₹25 Cr₹-1 Cr₹0 Cr₹3 Cr₹2 Cr₹1 Cr₹0 Cr₹-1 Cr
EPS4.54————0.26——
Balance Sheet
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹6 Cr₹36 Cr₹100 Cr₹176 Cr₹240 Cr₹258 Cr₹310 Cr₹337 Cr
Total Liabilities₹3 Cr₹8 Cr₹35 Cr₹63 Cr₹57 Cr₹57 Cr₹79 Cr₹88 Cr
Equity₹4 Cr₹28 Cr₹65 Cr₹113 Cr₹183 Cr₹201 Cr₹232 Cr₹249 Cr
Total Debt————————
Cash Flow
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹-1 Cr₹-13 Cr₹3 Cr₹40 Cr₹18 Cr₹12 Cr₹-32 Cr₹0 Cr
Investing₹0 Cr₹0 Cr₹-6 Cr₹-28 Cr₹-11 Cr₹-1 Cr₹-22 Cr₹-21 Cr
Financing₹0 Cr₹18 Cr₹4 Cr₹0 Cr₹26 Cr₹30 Cr₹34 Cr₹0 Cr
Free Cash Flow₹-1 Cr₹-13 Cr₹3 Cr₹40 Cr₹16 Cr₹12 Cr₹-32 Cr₹0 Cr
Shareholding
Promoter 65.99% Institutions 2.56% Public 31.45%
Efficiency & Working Capital
ROCE3%
Interest Coverage2.1
Dividend Payout—
Debtor Days184 d
Inventory Days113 d
Payable Days29 d
Cash Conversion Cycle268 d
Working Capital Days297 d
Shareholding Details

As of 2026-06-30

Promoter66%
FII0%
DII2.6%
Institutions2.6%
Public31.4%
Promoter Pledge0%
No. of Shareholders14,682
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodMar 2024Apr 2024Apr 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters66.4%66.4%66.4%66%66%66%66%66%66%66%66%66%
FIIs17.1%17.1%17.1%16.9%16.5%16.5%16%8.9%3.5%1.7%0%0%
DIIs0%0%0%0%0%0%0%0%0%0%2.6%2.6%
Public16.5%16.5%16.5%17.1%17.5%17.5%18%25.1%30.5%32.2%31.4%31.4%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders5,1325,1325,1326,5867,8638,5299,99413,73714,62015,08515,17614,682
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603————
Major Shareholders (>1%)
NameCategoryStakeShares
Balaxi Overseas Private LimitedShareholding of Promoter and Promoter Group63.4%3.50 Cr
Rgsl Investment Fund - Rgsl Investment Lvf 1Public Shareholding2.5%14,00,537
Kunal Mahendra BhaktaPublic Shareholding1.9%10,28,855
Ashish MaheshwariShareholding of Promoter and Promoter Group1.6%9,03,870
Amol Anand MantriPublic Shareholding1.4%7,78,176
P P Zibi JosePublic Shareholding1.3%7,10,821
Minoshi MaheshwariShareholding of Promoter and Promoter Group1%5,27,900
Board of Directors
NameDesignationYear
Ashish MaheshwariManaging Director2024
Minoshi MaheshwariNon Executive Director2024
Kunal M BhaktaIndependent Non Exe. Director2024
Gandhi GamjiIndependent Non Exe. Director2024
M. Srinivas RaoIndependent Non Exe. Director2024
Mohith Kumar KhandelwalCompany Sec. & Compli. Officer2024
Segments — Product
SegmentRevenueShare
Specialized Wholesale₹0 Cr—
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹2401111
Corporate Actions
TypeDateValueRemark
forthcoming2026-08-05Board Meetings—
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
20261360020137
202654000054
2026000202
Company Information
Incorporated1942
AuditorP Murali & Co
Investor Email[email protected]
🌐 www.balaxipharma.in ↗

📍 41/298-D2 2nd Flr Saniya Plaza, Mahakavi Bharatiyar Road, Cochin, Kerala, 682035

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Bajel Projects LimitedBajaj Finance LimitedShree Tirupati Balajee Agro Trading Co. Ltd.Balaji Phosphates LimitedBalaji Telefilms Limited.Balaji Amines LimitedSolve Plastic Products LimitedBalkrishna Paper Mills LimitedBalkrishna Industries Ltd.Balmer Lawrie & Company Ltd.Bal Pharma Ltd.Balrampur Chini Mills Ltd.All “B” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search